Skip to main content
TipRanks
Go Ultimate75% OFF

TransMedics Group (TMDX) Revenue by Type

1,906 Followers

Revenue by Type

TransMedics Group reported revenue by type of $203.00M in Q3 2026, up 6.9% from Q2 2026 and up 41.1% year over year. This is the highest value since 2022.

Shows how much revenue comes from device sales, consumables/disposables, and services. For TransMedics, a larger share of recurring consumables and service revenue signals steadier growth and less dependence on one-time system sales, while reliance on capital equipment can make results lumpy and more sensitive to hospital purchasing cycles.

$0.00$50.00M$100.00M$150.00M$200.00MMar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

TransMedics’ growth is increasingly service‑led: services have scaled into a material share of revenue, fueling record top‑line momentum and more recurring, logistics-driven dollars while product sales grow more unevenly. That mix helped lift revenue guidance but explains the YoY margin pressure management flagged; PAD consolidation and heavy R&D investments will likely keep near-term margins muted even as the company bets on organic momentum and multi‑year scale toward its >$2B revenue goal.

TMDX Revenue by Type

PeriodProductServiceTotal
Q3 2026Sep 30, 2026$113.42M$89.59M$203.00M
Q2 2026Jun 30, 2026$111.16M$78.79M$189.95M
Q1 2026Mar 31, 2026$107.97M$65.96M$173.93M
Q4 2025Dec 31, 2025$100.39M$60.37M$160.76M
Q3 2025Sep 30, 2025$87.68M$56.15M$143.82M
Q2 2025Jun 30, 2025$96.10M$61.27M$157.37M
Q1 2025Mar 31, 2025$88.23M$55.30M$143.54M
Q4 2024Dec 31, 2024$74.95M$46.68M$121.62M
Q3 2024Sep 30, 2024$65.86M$42.90M$108.76M
Q2 2024Jun 30, 2024$71.73M$42.57M$114.31M
Q1 2024Mar 31, 2024$61.33M$35.52M$96.85M
Q4 2023Dec 31, 2023$51.87M$29.30M$81.17M
Q3 2023Sep 30, 2023$47.74M$18.69M$66.43M
Q2 2023Jun 30, 2023$42.46M$10.00M$52.47M
Q1 2023Mar 31, 2023$33.99M$7.56M$41.55M
Q4 2022Dec 31, 2022$25.07M$6.30M$31.38M
Q3 2022Sep 30, 2022$21.30M$4.38M$25.68M
Q2 2022Jun 30, 2022$17.92M$2.60M$20.52M
Q1 2022Mar 31, 2022$14.94M$941.00K$15.88M

Related KPIs